Company profile for Ablaze Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China. We will leverage on the company's founders' extensive business experience and network in cross-border drug development and trading to promote innovative TRT products to the Chinese market. We strive to become the leader and preferred partner of China's emergi...
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China. We will leverage on the company's founders' extensive business experience and network in cross-border drug development and trading to promote innovative TRT products to the Chinese market. We strive to become the leader and preferred partner of China's emerging TRT market through cooperation with strategic business partners at home and abroad.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room 122, 3rd Floor, No. 696, Weihai Road, Shanghai
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/ablaze-pharmaceuticals-plans-development-of-innovative-gpc3-targeted-radiopharmaceutical-therapy-for-liver-cancer-in-greater-china-301786152.html

PR NEWSWIRE
31 Mar 2023

https://www.prnewswire.com/news-releases/ablaze-pharmaceuticals-and-yonghe-pharma-initiate-development-and-manufacturing-services-agreement-for-targeted-radiopharmaceutical-therapies-301709927.html

PRNEWSWIRE
27 Dec 2022

https://www.indianpharmapost.com/news/ablaze-and-yonghe-pharma-initiate-development-and-manufacturing-agreement-for-targeted-radiopharmaceutical-therapies-13512

INDIANPHARMAPOST
27 Dec 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-08-08/ablaze-pharma-and-wenjiang-district-gov-of-chengdu-sign-strategic-agreement/?widget=listSection

CONTRACTPHARMA
08 Aug 2022

https://www.prnewswire.com/news-releases/ablaze-pharma-aligned-the-strategic-agreement-with-wenjiang-district-government-of-chengdu-to-build-up-the-innovative-rd-and-manufacturing-center-for-targeted-radiopharmaceutical-therapies-301597950.html

PRNEWSWIRE
02 Aug 2022

ABOUT THIS PAGE

Contact Ablaze Pharma and get a quotation

Ablaze Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Glutaraldehyde bulk with CEP offered by Ablaze Pharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty